These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35943399)

  • 1. Treatment of Cannabis Hyperemesis Syndrome Using Haloperidol in a Pregnant Patient: Case Report.
    La Sala MS; Constantino E; Koola MM; Yel I; Chacko M
    J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):506-508. PubMed ID: 35943399
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cannabinoid hyperemesis syndromecan be relieved by hot showers].
    Søndermølle MB; Randers E
    Ugeskr Laeger; 2021 Apr; 183(15):. PubMed ID: 33913422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial.
    Moussa G; Genest M; Villeneuve E; Wang JJ
    Ann Emerg Med; 2021 May; 77(5):555. PubMed ID: 33902836
    [No Abstract]   [Full Text] [Related]  

  • 4. Haloperidol for treatment of cannabinoid hyperemesis syndrome.
    Hickey JL; Witsil JC; Mycyk MB
    Am J Emerg Med; 2013 Jun; 31(6):1003.e5-6. PubMed ID: 23583118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural language processing improves estimates of the epidemiology of cannabinoid hyperemesis syndrome.
    Hewitt M; Ma P; Coyle E; Leidlein S; Jennings K; Wanis N; Miller J
    Am J Emerg Med; 2023 Aug; 70():198-199. PubMed ID: 37349236
    [No Abstract]   [Full Text] [Related]  

  • 6. Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome?
    Inayat F; Virk HU; Ullah W; Hussain Q
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28052951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid Hyperemesis Syndrome During Pregnancy: A Case Report.
    Andrews KH; Bracero LA
    J Reprod Med; 2015; 60(9-10):430-2. PubMed ID: 26592070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial.
    Ruberto AJ; Sivilotti MLA; Forrester S; Hall AK; Crawford FM; Day AG
    Ann Emerg Med; 2021 Jun; 77(6):613-619. PubMed ID: 33160719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurring vomiting, skin discolouration: the easily overlooked thermal element of cannabinoid hyperemesis syndrome.
    Ali AA; Mathew R; Maaliki N; Shelley P
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33762293
    [No Abstract]   [Full Text] [Related]  

  • 10. Capsaicin topical in emergency department treatment of cannabinoid hyperemesis syndrome.
    Waterson Duncan R; Maguire M
    Am J Emerg Med; 2017 Dec; 35(12):1977-1978. PubMed ID: 28712644
    [No Abstract]   [Full Text] [Related]  

  • 11. Cannabinoid hyperemesis syndrome: a case report and review of pathophysiology.
    Iacopetti CL; Packer CD
    Clin Med Res; 2014 Sep; 12(1-2):65-7. PubMed ID: 24667219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid hyperemesis syndrome.
    Parekh JD; Wozniak SE; Khan K; Dutta SK
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cyclical hyperemesis secondary to cannabis abuse].
    Ochoa-Mangado E; Jiménez Giménez M; Salvador Vadillo E; Madoz-Gúrpide A
    Gastroenterol Hepatol; 2009; 32(6):406-9. PubMed ID: 19477551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hot bath to calm what ails you: the Cannabis Hyperemesis Syndrome.
    Luther V; Yap L
    Acute Med; 2012; 11(1):23-4. PubMed ID: 22423343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cannabinoid hyperemesis syndrome causing prolonged nausea and vomiting in patients with cannabis abuse].
    Naver AV; Theede K
    Ugeskr Laeger; 2015 Apr; 177(18):. PubMed ID: 25922240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol as an anti-emetic for Cannabis Hyperemesis Syndrome in the ED.
    Trajkovski A; Lang E
    CJEM; 2021 May; 23(3):312-313. PubMed ID: 33835429
    [No Abstract]   [Full Text] [Related]  

  • 17. Cannabis hyperemesis syndrome: Incidence and treatment with topical capsaicin.
    Burillo-Putze G; Trujillo-Burillo D; García-Hernandez JC; López-Hernández MA; Hernández-Ramos I; Ramos-Suárez I; Richards JR
    Med Clin (Barc); 2022 Aug; 159(4):183-186. PubMed ID: 34756408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Cannabinoid Hyperemesis With Olanzapine: A Case Series.
    Hsu J; Herrmann Z; Kashyap S; Claassen C
    J Psychiatr Pract; 2021 Jul; 27(4):316-321. PubMed ID: 34398582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cytochrome P450 enzyme genetic variants in cannabis hyperemesis syndrome-A case report.
    Kuzin M; Xepapadakos F; Scharrer I; Augsburger M; Eap CB; Schoretsanitis G
    Basic Clin Pharmacol Toxicol; 2021 Jul; 129(1):82-85. PubMed ID: 33740842
    [No Abstract]   [Full Text] [Related]  

  • 20. Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series.
    Graham J; Barberio M; Wang GS
    Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29122973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.